Companies /Basic Materials

Eastman Chemical Company

NYSE: EMN Specialty Chemicals
$68.29
▼ $2.10 (−2.98%) today
Markets closed · 4:58pm ET

Q3 2025 Earnings

Reported Nov 3, 2025, 4:19pm ET · SEC source
$1.14
Miss −2.16%
EPS · est. $1.17
$2.2B
Miss −3.23%
Revenue · est. $2.3B
−0.3%
Trailing market
EMN vs S&P since report
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
0+3%+6%Nov 3Nov 4report 4:19pm ETearnings−1.2%+6.3%
0+3%+6%Nov 3Nov 4earnings−1.2%+6.3%
EMN +6.3%S&P 500 −1.2%
0+3%+6%Nov 3Nov 4report 4:19pm ETearnings−2.1%+6.3%
0+3%+6%Nov 3Nov 4earnings−2.1%+6.3%
EMN +6.3%NASDAQ −2.1%
−3%0+3%+6%Nov 3Nov 11report 4:19pm ETearnings−0.0%+5.3%
−3%0+3%+6%Nov 3Nov 11earnings−0.0%+5.3%
EMN +5.3%S&P 500 −0.0%
−4%0+4%Nov 3Nov 11report 4:19pm ETearnings−1.6%+5.3%
−4%0+4%Nov 3Nov 11earnings−1.6%+5.3%
EMN +5.3%NASDAQ −1.6%
+4.92%
Day of report
+0.58%
Next session
+0.31%
One week
+1.30%
30 days

S&P 500 over the same 30 days: +1.55%.

Did EMN Beat Earnings? Q3 2025 Results

Eastman Chemical delivered a disappointing third quarter, missing on both the top and bottom lines as weakening consumer demand and an unusual inventory unwind weighed heavily on results. Adjusted EPS came in at $1.14, falling short of the $1.17 consensus estimate by 2.16%, while revenue dropped 10.6% year-over-year to $2.20 billion, trailing analyst expectations of $2.28 billion by 3.23%. The primary culprit was a customer-driven destocking cycle, as buyers unwound tariff-related inventory prepositioned in the first half of the year, compressing volumes across all four operating segments and forcing aggressive inventory reduction actions that weighed on asset utilization. Fibers bore the sharpest pain, with revenue down 24% on acetate tow destocking and softer China textiles demand, while Chemical Intermediates fell 16% on weak building and construction activity. Despite the shortfall, management maintained full-year 2025 adjusted EPS guidance of $5.40 to $5.65 with operating cash flow approaching $1.00 billion, underpinned by more than $75.00 million in targeted net cost savings, though analysts have trimmed price targets following the softer outlook.

Key Takeaways
  • Weakness in consumer discretionary end markets including building and construction, consumer durables, and auto aftermarket
  • Customer unwinding of tariff-related inventory prepositioned in first half of 2025
  • Aggressive inventory management actions driving approximately $200 million inventory reduction from Q2 levels
  • Substantially lower asset utilization to drive cash generation
  • Competitive spread compression in Chemical Intermediates
  • Commercial excellence in defending prices and market share across specialty businesses
  • Cost structure reduction actions partially offsetting volume headwinds

“Our third-quarter financial results reflect the actions we took to reduce inventory and prioritize cash generation. With the weak macroeconomic environment persisting, our focus on cash generation, disciplined capital allocation, and structural cost reduction is more important than ever. As expected, in the third quarter we realized a slowdown in orders due to normal seasonality and customers unwinding inventory that was prepositioned to avoid tariff risk in a weakening consumer environment. In this context, our teams demonstrated continued commercial excellence in defending both prices and market share. We also made good progress on securing Renew rPET contracts for a significant ramp up in sales volume next year. We are taking a number of actions expected to create earnings growth next year and position the company for a strong recovery when the economy stabilizes.”

Eastman Chemical CEO, on the earnings call

Forward Guidance & Outlook

For Q4 and full-year 2025, Eastman expects a greater-than-normal seasonal decline in volume as the macroeconomic environment remains challenging, especially in consumer discretionary markets (building and construction, consumer durables, auto aftermarket). Management sees signs of increasing consumer caution and trade-down behavior. Customers are expected to continue unwinding tariff-related prepositioned inventory, with most depleted by year-end. The company expects price-cost stability, a modest increase in revenue from the Kingsport methanolysis facility, lower planned shutdown costs, and a modest asset utilization tailwind after substantially completing inventory reduction actions in Q3. Cost reductions are on track to exceed $75 million net of inflation in 2025, with an additional approximately $100 million net of inflation targeted for 2026. Full-year 2025 adjusted EPS is projected at $5.40 to $5.65, with operating cash flow approaching $1 billion.

EMN YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$700.0M$1.4B$2.1B$2.5B$2.2BRevenue$605.0M$433.0MGross Profit$357.0M$188.0MOperating Income$180.0M$47.0MNet Income
$0$700.0M$1.4B$2.1BRevenueGross ProfitOperating IncomeNet Income

EMN Revenue by Segment

Advanced Materials$728.0M−7.0%
Additives & Functional Products$716.0M−4.0%
Chemical Intermediates$499.0M−16.0%
Fibers$254.0M−24.0%

EMN Revenue by Geography

North America$972.0M
EMEA$563.0M
Asia Pacific$534.0M
Latin America$133.0M

Figures from SEC filings and company reports. Not investment advice.